See how early patient inclusion, integrated regulatory planning, and seamless CRO partnerships can help biotechs accelerate ...

New results from the Phase III MATTERHORN trial show AstraZeneca’s Imfinzi combination reduced the risk of death by 22% versus chemotherapy alone, marking a major advance for patients with resectable ...

Gain insight into why early toxicology readiness and strong scientific collaboration with CRO partners are critical to ...

Praxis Precision Medicines has shared positive data from its Phase III Essential3 clinical trial program (NCT06087276) assessing ulixacaltamide in essential tremor (ET). Across two studies, the small ...

Designing adhesion and durability for biopharmaceuticals in the most extreme cold chain environments.

This is the Applied Clinical Trials Brief —your fast track to the latest insights in clinical research operations. In under ...

Take a closer look at how agentic AI can automate repetitive monitoring tasks while keeping human oversight central to ...

Eli Lilly’s oral GLP-1 therapy, orforglipron, met all primary and key secondary endpoints in the Phase III ACHIEVE-2 and ACHIEVE-5 studies, showing significant A1C reduction, weight loss, and ...

Gain perspective on how agentic AI can bridge eCOA, EDC, IRT, and CTMS platforms to reduce manual effort and improve ...

Learn how streamlined confidentiality agreements and consistent workflows can speed site activation and improve sponsor-site ...

Uncover how improving data accuracy and leveraging synthetic control arms can optimize trial efficiency, reduce costs, and ...

Understand how intelligent study design, focused data collection, and faster analytics can help clinical teams deliver meaningful results that sustain investor momentum.